44 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
and abuse, false claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our product
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
regulatory scrutiny;
the effects of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health information
424B4
j3xg245 mt6
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
5g1ktz5
5 Oct 23
Free writing prospectus
5:05pm
FWP
9k1 wtfa3hxpzdotwi4
3 Oct 23
Free writing prospectus
5:47pm
424B3
8jy7p5nh0
28 Jun 23
Prospectus supplement
4:56pm
424B3
t3ep963cpk2v
4 May 23
Prospectus supplement
4:30pm
424B4
121lr96anqi1gf12c4k
11 Oct 22
Prospectus supplement with pricing info
8:27am